Trials / Completed
CompletedNCT01002677
Behavioral Trial Studying Programmed Training to Improve Advocacy Skills for Individuals With Traumatic Brain Injury
Midwest Advocacy Project: A Community-based Randomized Practical Behavioral Trial of Programmed Advocacy Training for Individuals With Traumatic Brain Injury and Their Significant Others
- Status
- Completed
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 234 (actual)
- Sponsor
- Mayo Clinic · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The Midwest Advocacy Project (MAP) is a community-based multiple-site randomized practical behavioral trial of advocacy skill training for individuals with traumatic brain injury (TBI), their families, and significant others. The purpose is to evaluate the efficacy of a 4-session advocacy training program to improve behavioral advocacy skills compared to self-directed advocacy training of the same session frequency. Groups will be randomly assigned to either a programmed group or a self-directed group in collaboration with the Brain Injury Associations of Minnesota, Iowa, and Wisconsin each year over the 5 year study period. The primary outcome is pre-post measures of written and verbal advocacy skill measured by the Advocacy Behavior Rating Scale. It is hypothesized that subjects who receive programmed advocacy training will show greater positive change on pre-post measures of advocacy skill measures than subjects receiving self-directed training.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Advocacy training curriculum | Day-long presentation of an advocacy training curriculum by the state's Brain Injury Association staff: One session per month for 4 consecutive months. |
| BEHAVIORAL | Self-directed | Day-long group-based self-directed advocacy training activity: One session per month for 4 consecutive months. |
Timeline
- Start date
- 2007-08-01
- Primary completion
- 2012-09-01
- Completion
- 2012-09-01
- First posted
- 2009-10-27
- Last updated
- 2013-01-17
Locations
3 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01002677. Inclusion in this directory is not an endorsement.